Synagis and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synagis (palivizumab) and Lovenox (enoxaparin sodium). Common drug interactions include thrombosis among females and respiratory syncytial virus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Synagis and Lovenox. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Synagis?

Synagis has active ingredients of palivizumab. eHealthMe is studying from 19,114 Synagis users. Check the latest studies of Synagis.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

On Jul, 13, 2026

23 people who take Synagis and Lovenox together, and have interactions are studied.

What are the common drug interactions of Synagis and Lovenox, by gender? *:

female:

Thrombosis (formation of a blood clot inside a blood vessel)
Activated partial thromboplastin time prolonged
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Aphakia (absence of the lens of the eye)
Blood creatinine increased
Blood fibrinogen increased
Blood gases
Blood potassium increased
Blood urea increased
Cerebral infarction (less blood supply to brain resulting tissue damage)

male:

Respiratory syncytial virus infection (viral disease of respiratory system)
Influenza
Injection site swelling
Insomnia (sleeplessness)
Lethargy (tiredness)
Mitral valve incompetence (inefficient heart valve)
Mitral valve stenosis (narrowing of mitral valve)
Oxygen saturation decreased
Post procedural complication
Pulmonary congestion (congestion in the lungs)

What are the common drug interactions of Synagis and Lovenox, by age (0-1 to 60+)? *:

0-1:

Respiratory syncytial virus infection (viral disease of respiratory system)
Influenza
Injection site swelling
Insomnia (sleeplessness)
Lethargy (tiredness)
Mitral valve incompetence (inefficient heart valve)
Mitral valve stenosis (narrowing of mitral valve)
Oxygen saturation decreased
Post procedural complication
Pulmonary congestion (congestion in the lungs)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Premature Baby: 4 people, 17.39%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 2 people, 8.70%
Respiratory Distress (difficulty in breathing): 2 people, 8.70%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Synagis and Lovenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously